Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2

Conditions

Leukemia, Myeloid, Acute 170Precursor Cell Lymphoblastic Leukemia-Lymphoma 99Hematologic Neoplasms 83Leukemia, Lymphocytic, Chronic, B-Cell 81Myelodysplastic Syndromes 65Leukemia 53Lymphoma 41Multiple Myeloma 39Leukemia, Myelogenous, Chronic, BCR-ABL Positive 31Lymphoma, Non-Hodgkin 30Burkitt Lymphoma 24Recurrence 22Leukemia, Myelomonocytic, Chronic 20Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 19Myeloproliferative Disorders 18Leukemia, Biphenotypic, Acute 18Neoplasms 17Lymphoma, Mantle-Cell 17Lymphoma, Large B-Cell, Diffuse 17Leukemia, B-Cell 16Hodgkin Disease 15Lymphoma, B-Cell 14Lymphoma, Follicular 13Anemia, Refractory, with Excess of Blasts 13Waldenstrom Macroglobulinemia 12Lymphoma, B-Cell, Marginal Zone 11Myelodysplastic-Myeloproliferative Diseases 9Leukemia, Hairy Cell 9Blast Crisis 9Melanoma 7

Interventions

Vancomycin 1Teicoplanin 1Ofloxacin 1Metronidazole 1Meropenem 1Ciprofloxacin 1Ceftazidime 1Cefepime 1Amikacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neutropenia × Other hematologic neoplasm × 30 days × Clear all
NCT00001620 2026-05-29

Screening for Hematology Branch Protocols

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
10,000 enrolled
Classical hematologyOther hematologic neoplasm

Cytopenia, Anemia, Disease, Hematologic Diseases, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡